LEVOFOLINATE DE CALCIUM ZENTIVA 10 mg/ml, solution for injection (IM/IV) bottle, 5 ml
Active ingredients: ACIDE LÉVOFOLINIQUE, Levoleucovorin calcium hydrate
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Solution for injectionbottle, 5 mlintramusculaire;intraveineuse
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- LEVOFOLINATE DE CALCIUM ZENTIVA 10 mg/ml, solution injectable (IM/IV)
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 flacon(s) en verre de 5 ml
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 29 Jan 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64127601CIP73695480CIP133400936954809Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACIDE LÉVOFOLINIQUEsolution | 10 mg · 1 ml de solution | FT |
| LÉVOFOLINATE DE CALCIUM HYDRATÉsolution | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
- 3 bottles of 5 mlCommercialized according to BDPM
- 3 bottles of 10 mlCommercialized according to BDPM
- 3 bottles of 17.5 mlCommercialized according to BDPM
- 5 bottles of 5 mlCommercialized according to BDPM
- 5 bottles of 10 mlCommercialized according to BDPM
- 5 bottles of 17.5 mlCommercialized according to BDPM
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.